1. Home
  2. CDNA vs FOR Comparison

CDNA vs FOR Comparison

Compare CDNA & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$28.90

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$30.40

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
FOR
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
CDNA
FOR
Price
$28.90
$30.40
Analyst Decision
Buy
Buy
Analyst Count
6
3
Target Price
$28.00
$32.67
AVG Volume (30 Days)
932.9K
139.0K
Earning Date
04-28-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.05
0.93
Revenue
$48,324,000.00
$1,662,400,000.00
Revenue This Year
$16.01
$0.34
Revenue Next Year
$11.31
$7.73
P/E Ratio
$582.20
$32.54
Revenue Growth
18.93
10.14
52 Week Low
$10.96
$21.54
52 Week High
$30.00
$32.06

Technical Indicators

Market Signals
Indicator
CDNA
FOR
Relative Strength Index (RSI) 65.45 55.78
Support Level $14.59 $23.88
Resistance Level N/A $30.74
Average True Range (ATR) 1.40 0.93
MACD 0.01 -0.16
Stochastic Oscillator 85.34 45.12

Price Performance

Historical Comparison
CDNA
FOR

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. The company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

Share on Social Networks: